|
|
|
Insider
Information: |
Kirk Randal J |
Relationship: |
10% Owner |
City: |
Radford |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,684,697 |
|
Indirect Shares
|
132,343,505 |
|
|
Direct
Value |
$200,615,941 |
|
|
Indirect Value
|
$516,931,851 |
|
|
Total
Shares |
136,028,202 |
|
|
Total
Value |
$717,547,792 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
5
|
0
|
|
|
|
Gain/Loss Ratio : |
-5.0
|
0.0
|
Percentage
Gain/Loss : |
-48.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
Precigen Inc |
PGEN |
|
|
0 |
2024-08-09 |
116,104,879 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
272 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PGEN |
Precigen Inc |
Executive Chairman |
|
2020-03-19 |
4 |
B |
$1.87 |
$1,098,311 |
I/I |
579,664 |
10,091,637 |
2.64 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2007-09-14 |
4 |
B |
$8.71 |
$1,112,206 |
I/I |
127,693 |
3,693,406 |
2.25 |
- |
|
PGEN |
Precigen Inc |
Executive Chairman |
|
2020-03-20 |
4 |
B |
$2.72 |
$1,143,314 |
I/I |
420,336 |
10,511,973 |
2.64 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2021-11-19 |
4 |
B |
$3.75 |
$1,153,729 |
I/I |
307,661 |
307,661 |
2.25 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-06-07 |
4 |
B |
$5.26 |
$1,169,587 |
I/I |
222,355 |
157,413 |
2.64 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-23 |
4 |
B |
$8.00 |
$1,328,800 |
I/I |
166,100 |
1,915,947 |
2.25 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-06-06 |
4 |
B |
$5.23 |
$1,364,575 |
I/I |
260,913 |
156,212 |
2.64 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-05-20 |
4 |
B |
$4.63 |
$1,396,732 |
I/I |
301,670 |
918,459 |
2.64 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-16 |
4 |
B |
$8.19 |
$1,437,509 |
I/I |
175,520 |
1,638,224 |
2.25 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-05-30 |
4 |
B |
$4.79 |
$1,473,366 |
I/I |
307,592 |
153,706 |
2.64 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2013-08-13 |
4 |
A |
$0.00 |
$1,501,600 |
I/I |
1,696,140 |
76,611 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-15 |
4 |
S |
$17.15 |
$1,569,928 |
I/I |
(91,541) |
3,041,722 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2013-08-13 |
4 |
A |
$0.00 |
$1,579,760 |
I/I |
1,880,737 |
73,668 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-08-10 |
4 |
B |
$6.13 |
$1,604,031 |
I/I |
261,669 |
1,000,000 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-16 |
4 |
S |
$17.24 |
$1,644,058 |
I/I |
(95,363) |
2,985,054 |
0 |
- |
|
PGEN |
Precigen Inc |
Executive Chairman |
|
2020-08-12 |
4 |
B |
$4.26 |
$1,707,689 |
I/I |
400,866 |
220,123 |
2.64 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2021-11-23 |
4 |
B |
$3.58 |
$1,741,079 |
I/I |
486,335 |
1,000,000 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-14 |
4 |
B |
$8.13 |
$1,788,600 |
I/I |
220,000 |
1,220,000 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-07-25 |
4 |
S |
$17.32 |
$1,799,548 |
I/I |
(103,900) |
3,734,865 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-12-07 |
4 |
B |
$5.55 |
$1,865,910 |
I/I |
336,200 |
1,182,000 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-24 |
4 |
S |
$18.20 |
$1,881,370 |
I/I |
(103,372) |
2,219,466 |
0 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2017-06-08 |
4 |
S |
$1.00 |
$1,975,000 |
I/I |
(1,975,000) |
786,613 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-15 |
4 |
B |
$8.18 |
$1,985,319 |
I/I |
242,704 |
1,462,704 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-27 |
4 |
S |
$18.22 |
$1,992,849 |
I/I |
(109,377) |
2,154,470 |
0 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-05-18 |
4 |
B |
$20.00 |
$2,000,000 |
I/I |
100,000 |
366,246 |
2.25 |
- |
|
272 Records found
|
|
Page 9 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|